Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Buildings: 2010-2016

Historic Buildings for BIO-TECHNE (TECH) over the last 4 years, with Jun 2016 value amounting to $158.0 million.

  • BIO-TECHNE's Buildings rose 0.64% to $158.0 million in Q2 2016 from the same period last year, while for Jun 2016 it was $158.0 million, marking a year-over-year increase of 0.64%. This contributed to the annual value of $158.0 million for FY2016, which is 0.64% up from last year.
  • As of Q2 2016, BIO-TECHNE's Buildings stood at $158.0 million, which was up 0.64% from $157.0 million recorded in Q2 2015.
  • BIO-TECHNE's Buildings' 5-year high stood at $158.0 million during Q2 2016, with a 5-year trough of $122.7 million in Q1 2012.
  • Its 3-year average for Buildings is $153.6 million, with a median of $153.7 million in 2014.
  • Data for BIO-TECHNE's Buildings shows a peak YoY rose of 16.27% (in 2013) over the last 5 years.
  • Over the past 5 years, BIO-TECHNE's Buildings (Quarterly) stood at $133.0 million in 2012, then grew by 10.98% to $147.7 million in 2013, then rose by 5.11% to $153.7 million in 2014, then increased by 5.03% to $157.0 million in 2015, then rose by 0.64% to $158.0 million in 2016.
  • Its last three reported values are $158.0 million in Q2 2016, $157.0 million for Q2 2015, and $153.7 million during Q3 2014.